4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-077496
Chief Medical Officer sold 6,925 shares at $7.22 ($49,999)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2024-06-25 | Sale 10b5-1 | −6,925 | $7.22 | $49,999 | 351,527 | D |
| Open-market sales · 6,925 sh · avg $7.22 · $49,999 | |||||||
Loading xslF345X05/ownership.xml…